#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Restless legs syndrome Pulmonary alveolar haemorrhage Immunodeficiency Dementia Alzheimer's type Pulmonary sarcoidosis Activated PI3 kinase delta syndrome Advanced systemic mastocytosis Acquired haemophilia Craniocerebral injury Interstitial lung disease Spina bifida Epidermolysis bullosa Fms-like tyrosine kinase 3 positive Vascular malformation Intracranial germ cell tumour More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Trials in Disease Chondrosarcoma – Treatment Bronchopulmonary dysplasia – Life with Disease Chondrosarcoma – Life with Disease Erdheim-Chester disease – Life with Disease Glycogen storage disease type I – Treatment Wolfram syndrome – Treatment Ewing’s sarcoma recurrent Hereditary motor and sensory neuropathy Stevens-Johnson syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VORMATRIGINE Efgartigimod Alfa Istaroxime Disulfiram Giroctocogene Fitelparvovec Mps-112 VAMIFEPORT TRIHYDROCHLORIDE Dexamethasone Sodium Phosphate Linezolid Albiglutide NALDEMEDINE Pyridoxine Hydrochloride Bp FOSMANOGEPIX Vincristine Alxn1850 Bexmarilimab Procarbazine Permethrin Valganciclovir Hydrochloride [99MTC]PSMA I&S More therapies…

    Learn about Your Condition

    Influenza Metachromatic leukodystrophy Exudative retinopathy Haematological malignancy Endocrine disorder Solitary fibrous tumour Meningorrhagia Piriformis syndrome Diabetic foot Spina bifida Dyspepsia Prostate cancer metastatic Breast angiosarcoma metastatic Cushing's syndrome Bronchitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. HNO Praxis Dr. Sonja Runge

HNO Praxis Dr. Sonja Runge

Rosa-Luxemburg-Damm 1, Neuenhagen, 15366, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • 12 Grass Pollen Mixture
    • Desloratadine
    • Grass Pollen Allergen Extract Modified With Glutaraldehyde And Adsorbed To L-Tyrosine
    Bulgaria Czechia Germany Lithuania Poland Romania +1

  • Testing benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • 2,4 DICHLOROBENZYL ALCOHOL
    • BENZYDAMINE HYDROCHLORIDE
    Germany

  • Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • 2,4 DICHLOROBENZYL ALCOHOL
    • BENZYDAMINE HYDROCHLORIDE
    Germany

  • Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Placebo
    Austria Germany Poland

  • Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
    Germany Poland

  • Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Betula Pollen Extract
    Austria Bulgaria Finland France Germany Hungary +6

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Agrostis Stolonifera Pollen
    • Alnus Glutinosa Pollen
    • Aluminium Hydroxide
    Austria Bulgaria Germany Latvia Lithuania Poland

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Azelastine Hydrochloride
    • Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
    • Betula Verrucosa Pollen
    Germany

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!